Gas Utilities

Spire

Spire Inc. Shifts to Regulated Model and Announces $11.2 Billion 10-Year CapEx Plan

Spire Inc. Reports Strong Q2 Earnings and Completes $2.5B Acquisition

Spire released FY2026 Semi-Annual earnings on May 6 Pre-Market EST, actual revenue USD 1.719 B, actual EPS USD 6.1428

Spire released FY2026 Q2 earnings on May 6 Pre-Market (EST), actual revenue USD 1.02 B (forecast USD 1.02 B), actual EPS USD 4.6012 (forecast USD 3.7223)

Spire to release FY2026 Q2 earnings on May 6 Pre-Market EST, forecast revenue USD 1.02 B, EPS USD 3.7223

I Squared Capital Agrees to Acquire Spire's Natural Gas Storage Assets for $650 Million

Spire Inc. Issues Senior Notes to Refinance Debt and Plan Acquisition

Spire released FY2026 Q1 earnings on February 3 Pre-Market (EST), actual revenue USD 762.2 M (forecast USD 723.89 M), actual EPS USD 1.54 (forecast USD 1.6155)

Spire Inc. reports Q1 earnings growth and investment plans

Spire to Release FY2026 Q1 Earnings on February 3, Pre-Market EST; Forecast Revenue USD 785.94 M, EPS USD 1.5666

Spire Inc's Subsidiary Issues $825 Million Senior Notes Due 2026

Spire Inc. issued $900 million subordinated bonds to acquire Duke Energy subsidiary natural gas business

Mizuho Securities Analyst Raises Spire Target Price to $96

Spire Inc. Announces $2.48 Billion Acquisition of Piedmont Natural Gas Company's Tennessee Distribution Business

Spire, Inc. to acquire Duke Energy's Piedmont Natural Gas business in Tennessee for $2.48 billion in cash

Spire released FY2025 annual earnings on November 14 Pre-Market (EST), actual revenue USD 2.476 B (forecast USD 2.534 B), actual EPS USD 4.37 (forecast USD 4.5735)

Spire released FY2025 Q4 earnings on November 14 Pre-Market (EST), actual revenue USD 334.1 M (forecast USD 439.56 M), actual EPS USD -0.7387 (forecast USD -0.5026)

Spire to Release FY2025 Q4 Earnings on November 14 Pre-Market EST, Forecast Revenue USD 439.56 M, EPS USD -0.5026

Jefferies Gives Spire a Buy Rating

Arcaro Analyzes Utility Industry Stocks

Freecast

Cuprina

U-BX Tech

HORIZON SPACE ACQUISITION II CORP COM USD0.0001 30/03/2026(SUB/RIGHTS)

Defiance Pure Space Dly 2X Strat ETF

VS MEDIA

Everbright Digital

Park Ha Biological Tech

Friedman Industries

Defiance Daily Target 2X Short ASTS ETF

Spire Inc. Senior VP Ryan Hyman sold US$308k worth of shares at $80.51, representing 21% of his holdings. This marks the largest insider sale in the past year. While insider selling is generally viewed negatively, the transaction occurred near current market prices, mitigating concerns. Insiders hold only 0.5% of Spire, suggesting limited alignment with shareholders. Despite recent sales outweighing purchases, the company's profitability and growth provide some reassurance, though investors are advised to consider associated risks.

Simplywall

This Insider Has Just Sold Shares In Spire

Spire (SR) Director Paul Koonce purchased 500 shares worth $39,230 on June 12, 2026, signaling insider confidence. Analyst sentiment is mixed: Morgan Stanley trimmed its outlook due to sector lag, while BofA raised its view citing strong utility growth despite weather-related resets. TipRanks' AI analyst rates SR as Neutral, highlighting low valuation and yield against negative free cash flow and weak technical momentum.

Tip Ranks

Morgan Stanley

Bank of America

MORGAN STANLEY DEP SHS EA REP 1/1000 SHS NON CUM PFD O

MORGAN STANLEY DEP SHS REPSTG 1/1000TH PFD SER Q

MORGAN STANLEY DEP SHS REPS 1/1000 7.125% PFD E

MORGAN STANLEY NON-CUM DEP SH REP 1/1000 PFD SER I

MORGAN STANLEY 4.875 DEP SHS REP 1/1000 NCUM PFD SR L

MORGAN STANLEY 6.5%DEP SHS REPSTG 1/1000 NON CUM SER P

MORGAN STANLEY DEP SHS REPS 1/1000 PFD SER 'A'

MORGAN STANLEY DEP SHS REPR 1/1000TH INT PFD SER 'F' FX

MORGAN STANLEY DEP SHS REP 1/1000 NON-CUM PFD STK SER K

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH INT NON CUM PFD QQ

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '5'

BANK OF AMERICA CORPORATION 7.25% NON-CUM PERP CONV PFD SER L

BANK OF AMERICA CORPORATION 5.875%NON CUM DEP SHS REP1/1000TH SER HH

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '2'

BANK OF AMERICA CORPORATION 5% DEP SHS REPR 1/1000TH NON CUM PFD LL

BANK OF AMERICA CORPORATION DEP SHARES REP 1/1000TH PERP PFD SER 'E'

BANK OF AMERICA CORPORATION INCOME CAPITAL OBLIG NTS DUE 15/12/2066

BANK OF AMERICA CORPORATION 4.375% DP SH RP 1/1000TH IN NON CU PF NN

BANK OF AMERICA CORPORATION DEP SH REP 1/1200TH PRF SER 1 USD25

BANK OF AMERICA CORPORATION 5.375%DEP SHS REP 1/1000TH NON CUM SR KK

BANK OF AMERICA CORPORATION 6%NON CUM DEP SHS EACH REP 1/1000 SER GG

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200 PFD SER 4 USD25

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH NON CUM PFD SER SS

BANK OF AMERICA CORPORATION 4.125%DEP SH REP 1/1000 PFD SER PP USD25

Bank of America Corp

Top Spire Insider Quietly Makes a Bold Move in the Market

BTIG analyst Alex Kania maintained a Buy rating on Spire (SR) with a $105 price target, while shares closed at $80.26. The broader market consensus for Spire is a Moderate Buy with an average target of $100.14.

Entergy

PPL Corporation Pref Shares PPLC 7.0  02/15/2029

BTIG Sticks to Their Buy Rating for Spire (SR)

Zacks Research has lowered its Q1 2027 EPS estimate for Spire Inc. (NYSE:SR) from $1.77 to $1.57. The consensus estimate for the full year is $4.00 per share. Analysts have mixed ratings on the stock, with a consensus target price of $96.22. Spire's recent quarterly earnings beat estimates, reporting $3.76 EPS. The company also announced a quarterly dividend of $0.825, with a yield of 3.8%. Insider buying activity was noted, with Director Paul D. Koonce increasing his stake by 40%.

Market Beat

Stifel Financial

UBS Group AG

Principal Financial

STIFEL FINANCIAL CORP 6.125% DEP SHS REP 1/1000 NON CU PF SR C

Stifel Financial Pref Share SFB 5.2 10/15/47

STIFEL FINANCIAL CORP 6.25%NON CUM DEP SHS REP 1/1000TH SER B

STIFEL FINANCIAL CORP 4.50% DEP SHS REP 1/1000TH PREF SHS SR D

Analysts Offer Predictions for Spire's Q1 Earnings (NYSE:SR)

Spire Inc.'s average stock price target has been reduced from $100.71 to $100.14, suggesting a potential upside of 15% based on the May 20 closing price. The consensus rating remains a 'Buy' from 7 analysts, with 5 Buys and 2 Holds.

TradingView

Factset Research

Spire Inc. Stock 12‑Month Price Target Cut to $100.14, Implies 15% Upside

Shares in Spire Healthcare surged 45% to 218p after the board indicated support for a £1bn bid from Toscafund, offering 250p per share, a 66% premium. Spire, which operates 38 hospitals and over 60 clinics, reported a 4.5% revenue increase to £1.6bn for 2025, though profit before tax fell by over 50%. The company is experiencing rising demand for private healthcare amid NHS challenges. Toscafund has until June 11 to make a firm offer. Experts suggest potential for higher bids due to the improving private care landscape in the UK.

cityam

Ramsay Health Care Limited

Spire Healthcare shares rocket after £1bn bid approach

UBS Group AG has reduced its stake in Spire Inc. (NYSE:SR) by 22.8%, now holding 384,203 shares after selling 113,454 shares in Q4. The firm’s investment in Spire is valued at approximately $31.77 million. Other investors have also made moves, with several acquiring new stakes. Analysts have mixed ratings on Spire, with a consensus rating of "Moderate Buy" and a target price of $95.44. Spire recently reported earnings of $3.76 per share, exceeding estimates, and announced a quarterly dividend of $0.825 per share, yielding 3.9%.

Jefferies Financial

Toronto Dominion Bank

UBS Group AG Cuts Position in Spire Inc. $SR

Spire Inc. reported strong Q2 earnings, with adjusted earnings of $224 million, reflecting an 18.6% year-over-year growth. The company completed a $2.5 billion acquisition in Tennessee, adding over 200,000 customers, funded without equity. Despite challenges from a mild winter and higher financing costs, Gas Utility earnings rose over 20%. Spire is simplifying its portfolio by divesting non-regulated segments, enhancing focus on regulated utilities. However, it lowered its Gas Utility earnings guidance for fiscal 2026 due to weather-related shortfalls, now expecting $275 million to $295 million. Regulatory adjustments in Missouri are expected to improve cash flow.

Spire Inc. Earnings Call Highlights Growth Amid Headwinds

BCRX

BioCryst Pharma (NASDAQ:BCRX) reported Q1 2026 net revenue of $148.3 million, meeting expectations, with strong new patient prescriptions. Despite a manufacturing issue affecting the pediatric formulation of Orladeo, the company maintains its 2026 revenue guidance of $625-$645 million. The development of Nevenibart is progressing well, with the Phase 3 Alpha Orbit trial nearing completion. The acquisition of Astria Therapeutics is ahead of schedule, contributing to a 17% year-on-year revenue increase. BioCryst remains focused on expanding its market presence and addressing pediatric needs in HAE prophylaxis.

benzinga_article

BioCryst Pharma

Proshares Ultra Nasdaq Biotech

Invesco Biotechnology & Genome ETF

Direxion S&P Biotech Bull 3X

ALPS Medical Breakthrough

VG Health

iShares Global Healthcare

iShares US Pharma

VanEck Biotech ETF

Ark Genomic Revolution ETF

SPDR S&P Biotech

iShares Biotechnology ETF

First Trust NYSE Arca Biotech Index Fd

Astria Therapeutics

Full Transcript: BioCryst Pharma Q1 2026 Earnings Call

Spire (NYSE:SR) reported Q2 2026 results, with adjusted EPS of $3.76, up from $3.17 last year, driven by new rates in Missouri and Alabama. The company acquired Piedmont Natural Gas Tennessee without external equity, focusing on regulated gas utilities. Spire provided FY 2026 EPS guidance of $3.90 to $4.10 and reaffirmed FY 2027 guidance, targeting 5-7% long-term growth. Strategic divestitures of Spire Storage, Spire Mississippi, and Spire Marketing are expected to enhance earnings visibility and risk profile, with operational excellence and regulatory engagement as key priorities.

Spire Reports Q2 2026 Results: Full Earnings Call Transcript

Spire(SR.US)